The goal of this program is to improve management of cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). After hearing and assimilating this program, the clinician will be better able to:Describe mechanism of bispecific T-cell engagers in cancer treatment.Identify clinical manifestations of and risk factors for CRS.Implement evidence-based monitoring and treatment strategies for ICANs.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 903 Queens Lane
Pricing
CME included with membership · $1,095/yr
| Platinum Membership | $1,095/yr |
Collected from the provider’s public pages · source
Specialties served/covered
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Breast Imaging
- Cardiac Anesthesia
- Cardiovascular Disease
- Clinical Cardiac Electrophysiology
- Critical Care Medicine
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Facial Plastic & Reconstructive Surgery
- Gastroenterology
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Head & Neck Surgery
- Hematology
- Hospice & Palliative Medicine
- Hospital Medicine
- Interventional Radiology
- Laryngology
- Medical Oncology
- Neonatal-Perinatal Medicine
- Nephrology
- Neuro Anesthesia
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neuroradiology
- Nuclear Medicine
- Obstetric Anesthesia
- Otology & Neurotology
- Pain Medicine
- Pediatric Anesthesia
- Pediatric Cardiology
- Pediatric Critical Care Medicine
- Pediatric Emergency Medicine
- Pediatric Gastroenterology
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Neurology
- Pediatric Otolaryngology
- Pediatric Radiology
- Pediatric Surgery
- Primary Care Sports Medicine
- Pulmonary Disease
- Regional Anesthesia & Acute Pain
- Rheumatology
- Rhinology
- Sleep Medicine
- Surgical Critical Care
- Surgical Oncology
- Thoracic Anesthesia
- Trauma Surgery
- Vascular Surgery
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Radiology
- Sports & Exercise Medicine
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Membership pricing — $1,095 / year
This provider prices CME through membership. Individual courses may also be sold separately.
See plans on audio-digest.orgListed by the provider
- Enduring / On-demand
- Credit · Up to 1.25 credits
- MOC · Up to 1.25 points
- Membership pricing
-
ReleasedSep 1, 2026
-
Last day to claim creditJan 22, 2029 2 years left
-
Physicians’ Education Resource Project ECHO(R): Navigating CRS and ICANS Related to CAR T-Cell Therapy: Prevention, Grading, and Management in Practice
-
MedAll +1 BRIDGE Community Oncology Readiness Academy | Workshop 3: Managing CRS, ICANS, and Infectious Complications
-
PRIME Education, Inc. (PRIME®) Managing the Storm: Taming CRS in the Era of Bispecific Antibodies
-
Learner’s Digest International (TM) Bispecific T-Cell Engager Therapy for CRS and ICANS/Resistance to Antiestrogen Therapy in ER-Positive Breast Cancer
-
Learner’s Digest International (TM) Advances in the Management of Brain Tumors
-
Learner’s Digest International (TM) CAR T-Cells and Bispecifics in Myeloma
